Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Analysts offered mixed reactions following Google's earnings report, with many adjusting their price targets due to concerns over rising CapEX and slowing cloud revenue growth ...

Citigroup promoted more than 8,500 workers as of January 1 as part of its year-end process, the bank said in a statement on ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

In the most recent quarter, Spotify said its gross margin increased to 31.1% from the prior year's 26.4%. Wall Street is ...

Citi expects Trade Desk (TTD) to continue delivering its “beat-and-raise cadence” in Q4 and sees an attractive setup into the report with ...

Economic uncertainty has been further fuelled by expectations of tax cuts, broad tariffs on imports, and mass deportations of undocumented immigrants, which economists warn could drive inflation ...

Citi lowered the firm’s price target on Merck (MRK) to $125 from $130 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the firm ...

This article focuses on the latest stock ratings and analyst calls on AI companies involved in digital advertising, drone ...

SouthState (NYSE:SSB) shares gained 1.4% in Monday afternoon trading after Citi Research upgraded the regional banking stock to Buy from Neutral on the back of better-than-expected results for the ...

Q4 profit updates on tap amid as bullish sentiment remains after a strong 2024 Last Updated: Jan. 13, 2025 at 7:59 a.m. ET First Published: Jan. 13, 2025 at 7:55 a.m. ET Share ...

As the first earnings cycle of 2025 is ramping up, so are the announcements of new share buyback authorizations. Among these announcements, three big-name U.S. stocks stick out so far, all of which ...